AzTrials
AzTrials

Sleep DeprivationHeavyNapNCT06789237

Daytime Napping and Weighted Blankets

A study testing weighted blanket and non-weighted blanket in people with Sleep Deprivation, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Daytime napping enhances energy restoration, cognitive function, and memory as well as reducing fatigue and improving overall performance. Weighted blankets have been used for improving sleep quality and as a rehabilitation tool for children with neurodevelopmental disorders. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Deprivation
What is being tested?
weighted blanket and non-weighted blanket
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteGreece
Study dates
7 Feb 2024to 15 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Capacity to consent

Who cannot join

  • history of mental illness
  • history of epilepsy
  • any acute or chronic condition that would limit the ability of the patient to participate in the study

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • School of Physical Education, Sports and Dietetics, TEFAA

    Trikala, Thessaly, GR42100

Other trials in Greece

About this study

Official title: The Effect of Various Types of Weighted Blanket on Daytime Napping: a Randomized Cross-over Clinical Trial

Daytime napping enhances energy restoration, cognitive function, and memory as well as reducing fatigue and improving overall performance. Weighted blankets have been used for improving sleep quality and as a rehabilitation tool for children with neurodevelopmental disorders. It is not known, however, whether weighted blankets can improve short-duration naps like day-time napping and what is the optimal weight of those blankets for achieving the best results. The purpose of the present study is to investigate for the first time the effect of 4 different weighted blankets on sleep parameters on daytime napping.

Read the detailed description

Study Design Subjects will be randomly assigned into 4 conditions each one week apart: 1) The Control condition (CON), where subjects will lay down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight, 2) The 7 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 7 kg; 3) The 9 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 9 kg; 4) The 14 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 14 kg. All measurements will be conducted at the same sleep lab, at the same time of the day, under controlled conditions, with a constant temperature of 22°C, and dimmed lighting (5 lux), while any possible external sound will be masked using white noise sound at 432 Hz and 55 decibels. The study is approved by the Human Research and Ethics Committee of the University of Thessaly (2329/07/02/2024). All Subjects will give their written informed consent prior to study participation.

Procedure All measurements will be performed in the Lifestyle Medicine Laboratory, at the Department of Physical Education and Sport Science of Trikala, in Thessaly, Greece.

Before the initiation of the study, subjects will complete a series of questionnaires and measurements related to overall health. Subjects will be connected to a portable EEG/EOG system (HST-mit-tablet, Somomedics AG, Randersacker, Germany) for staging sleep architecture. Before and after each condition, subjects will complete a relaxation sensation questionnaire (RSQ) for assessing the state of relaxation and perform 3 maximum handgrip attempts using the dominant hand for assessing the level of muscle strength. Measurements of vital signs such as heart rate and blood pressure will also be recorded with an automatic blood pressure monitor [OMRON Bronze Upper Arm Blood Pressure Monitor]. All the assessments will be conducted on a supine position prior to study initiation. The participants will be free to either sleep or stay awake during the whole intervention period. Furthermore, to ensure result validity and avoid familiarization effects, a random 25% sample of participants will be selected for an additional measurement to determine whether the findings will be influenced by familiarity with the laboratory environment.

Measuring Instruments Body Composition Body composition will be assessed using anthropometric measurements including BMI, and bioimpedance (Tanita DC-360 S, Serinth) under standard methodology.19

Questionnaires The following questionnaires will be administered using the interview method by experienced researchers. The Pittsburgh Sleep Quality Index (PSQI) will be used to assess sleep quality and the existence of any sleep abnormalities. The Short Form survey 36-item 36 quality of life questionnaire (SF-36) will be used to assess the quality of life. The Beck Depression Inventory (BDI) questionnaire will be used to assess depressive symptoms and signs. The Perceived Stress Scale (PSS) will be used to assess the level of stress. Finally, the Relaxation State Questionnaire (RSQ) will be used to assess state of relaxation.

Brain Activity / Sleep Architecture A portable sleep monitoring system will be used to assess sleep quality and quantity (Home Sleep Test, Somnomedics, GmbH, Germany). The system records EEG, EOG, and EMG signals overnight. EEG data will analyzed in 30-second epochs using SomnoMed-ics PSG analysis software (Domino panel ver. 3.0.0.8) with manual editing. Analysis of the sleep study will be reported as followed: Total Sleep Time (total amount of sleep time scored during the total recording time); Sleep Efficiency (Total sleep time/Time in bed); Sustained Sleep Efficiency (Total sleep time/(Time in bed - Sleep laten-cy stage 2); Sleep Latency (the period of time it takes for a person to fall asleep after they have gone to bed and tried to initiate sleep); Sleep Latency N1 (the period of time between wakefulness and when sleep begins); Sleep Latency N2 (the period of time between time in bed and sleep onset stage 2); REM Latency (the amount of time elapsed between the onset of sleep to the first REM stage); Wakes (the number of times an individual wakes up during the sleep period or transitions to full wakefulness after sleep onset).

Handgrip strength assessment The handgrip test will be used for the assessment of maximum isometric strength of the dominant hand and arm muscles (Marsden MG-4800 Hand Dynamometer) and used as a measurement of muscle tone alertness. Reduction of muscle strength after the intervention, will be assessed as reduction of muscle tone.

Statistical Analysis The statistical analysis will be performed using IBM SPSS Statistics version 29 (SPSS Inc., Chicago, U.S.A.) An independent samples T-test will be used to examine differences in baseline characteristics and questionnaires between male and female subjects. A General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all parameters among the 4 different conditions. Additionally, a General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all sleep parameters among the 4 different conditions between good and poor sleepers. A Regression Linear Model will be applied to evaluate the relationship between EEG parameters and the weight of the blankets used. Statistical significance will be set at p≤0.05. Data are presented as mean ± standard deviation (SD), unless otherwise specified. A Bonferroni post-hoc test will be performed to assess individual differences. To assess normality, the Shapiro-Wilk test will be used alongside graphical representations, including the Normal Q-Q plot, Detrended Normal Q-Q plot, and Box Plot. The significance level will be set at 5%. Beyond significance testing (p-value), the effect size will be also considered to evaluate the magnitude of the effect.

Power Analysis Sample size calculations have been conducted using G*Power 3.1. The post-hoc "GLM": Repeated measures, within factors" method has been used to calculate the power analysis. The resulting minimum required sample size to achieve 85% power will be 14 participants for 2-sided group-1 and group-2 errors 5% [(Effect size 0.60, Critical F 4.10, Ndf 2, Ddf 10, Power (1-β err pob) = 0.86 (86% power)].

Being tested
weighted blanket, non-weighted blanket
Keywords
daytime nap, power naps
Medical subject headings
Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • weighted blanketOther

    Participants will be covered with a weighted blanket for 30 minutes

  • non-weighted blanketOther

    Participants will be covered with a sham non-weighted blanket for 30 minute

Study groups in NCT06789237
Study groupRoleWhat they receive
ControlSham comparatorFor the Control condition (CON), subjects will lie down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight,
Receives: Other: non-weighted blanket
7 Kg blanketExperimentalFor the 7 kg condition blanket, subjects will lie down and be covered with a blanket weighing 7 kg
Receives: Other: weighted blanket
9 Kg blanketExperimentalFor the 9 kg condition blanket, subjects will lie down and be covered with a blanket weighing 9 kg
Receives: Other: weighted blanket
14 Kg blanketExperimentalFor the 14 kg condition blanket, subjects will lie down and be covered with a blanket weighing 14 kg
Receives: Other: weighted blanket

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Sleep Time

    Total Sleep Time is the total amount of sleep time scored during the total recording time

    Measured: At the end of the 30 minutes intervention

  2. Sleep Efficiency

    Sleep Efficiency is the ration of Total sleep time/Time in bed

    Measured: At the end of the 35 minutes intervention

Secondary outcomes (1)
  1. Relaxation Score

    The Relaxation score will be calculated by the Relaxation State Questionnaire assessing the state of relaxation before and after the intervention. The RSQ score ranges from 10 to 50 with a higher score implying a better outcome (the larger the number, the more relaxed is the person).

    Measured: At baseline and after the 30 minutes intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2025
  2. Study start7 Feb 2024
  3. Primary completion15 Aug 2024
  4. Study completion15 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06789237
Sponsor's protocol ID
2329/07/02/2024
Acronym
HeavyNap
Status last verified
Jan 2025
First submitted
17 Jan 2025
Last updated
28 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Raw data and study IRB protocol

Publications

  • Mullen B, Champagne T, Krishnamurty S, Dickson D, Gao RX. Exploring the safety and therapeutic effects of deep pressure stimulation using a weighted blanket. Occup Ther Ment Health. 2008;24(1):65-89.

  • Dutheil F, Danini B, Bagheri R, Fantini ML, Pereira B, Moustafa F, Trousselard M, Navel V. Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Sep 28;18(19):10212. doi: 10.3390/ijerph181910212.

    PubMed 34639511

Questions about this trial

What is this clinical trial studying?

A study testing weighted blanket and non-weighted blanket in people with Sleep Deprivation, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Sleep Time (time frame: At the end of the 30 minutes intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06789237, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in